WVP
APYX icon

Worth Venture Partners’s Apyx Medical APYX Stock Holding History

Worth Venture Partners’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-518,198
Closed -$1.36M – 70
2023
Q4 		$1.36M Buy
518,198
+55,592
+12% +$135K 0.73% 52
2023
Q3 		$1.48M Buy
462,606
+153,144
+49% +$714K 0.88% 42
2023
Q2 		$1.56M Buy
309,462
+179,691
+138% +$910K 0.85% 36
2023
Q1 		$374K Buy
+129,771
New +$379K 0.18% 99

Other funds holding APYX

ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCA
Greenwood Capital Associates Greenwood, South Carolina $1.02B AUM 28.26% 1-Year Est. Return

Worth Venture Partners's APYX Position: Q1 2024 in Review

Worth Venture Partners sold out of Apyx Medical (APYX) in Q1 2024, closing a stake of 518,198 shares — an estimated $1.36M sold.

Worth Venture Partners first reported a position in APYX in Q1 2023 and held it in 4 quarters. The position peaked at $1.56M in Q2 2023. 51 funds tracked by Wall St. Rank hold APYX as of Q1 2024.

  • Worth Venture Partners reported no remaining Apyx Medical position as of Q1 2024 after selling out during the quarter.
  • Worth Venture Partners sold 518,198 Apyx Medical shares in Q1 2024, an estimated $1.36M.
  • Worth Venture Partners first reported a position in Apyx Medical in Q1 2023 and held it in 4 quarters.
  • Worth Venture Partners's Apyx Medical position peaked at $1.56M in Q2 2023.
  • 51 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2024.

Based on Worth Venture Partners's 13F filing for Q1 2024, filed 13 May 2024.